HWH International Inc HWH Holds Steady Near Support Amidst Low Volume Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration for Radiopharmaceutical Clinical Development ARQT Q1 2026 Earnings WiderthanExpected Loss as Company Advances Dermatology Pipeline Sanctions Fuel Innovation Huawei and the Hers Law Challenge